Vestal Point Capital »

Insmed shares owned by Vestal Point Capital

Quarter-by-quarter ownership of Insmed (INSM) shares owned by Vestal Point Capital from 13F filings

Historical chart of Vestal Point Capital investment in Insmed

Tip: Access up to 7 years of quarterly data

All positions including Insmed held by Vestal Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Insmed by Vestal Point Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $50M 750k 67.00

More positions owned by Vestal Point Capital

Jazz Pharmaceuticals Shs Usd (JAZZ)
Cytokinetics Com New (CYTK)
Ascendis Pharma A/S Sponsored Adr (ASND)
Ultragenyx Pharmaceutical (RARE)
Globus Medical Cl A (GMED)
Insmed Com Par $.01 (INSM)
BeiGene Sponsored Adr (BGNE)
Soleno Therapeutics (SLNO)
EXACT Sciences Corporation (EXAS)
Arcellx Common Stock (ACLX)
Immatics NV SHS (IMTX)
Janux Therapeutics (JANX)
Astria Therapeutics (ATXS)
Kalvista Pharmaceuticals (KALV)
Savara (SVRA)

View all positions for Vestal Point Capital

Top funds holding Insmed

Vanguard Group
BlackRock
T. Rowe Price Associates
State Street Corporation
Geode Capital Management
Baker Bros. Advisors
Darwin Global Management
William Blair Investment Management
Jpmorgan Chase & Co
Macquarie Group
Franklin Resources
Suvretta Capital Management
Alliancebernstein
Artisan Partners Limited Partnership
T. Rowe Price Investment Management

View all funds holding Insmed